대한후두음성언어의학회지 (Journal of the Korean Society of Laryngology, Phoniatrics and Logopedics)

  • 제29권2호
  • /
  • Pages.87-93
  • /
  • 2018
  • /
  • 2508-268X(pISSN)
  • /
  • 2508-5603(eISSN)
대한후두음성언어의학회 (The Korean Society of Laryngology, Phoniatrics and Logopedics. )
권호 표지

인후두 역류질환에서 N-Acetyl Cysteine의 증상 개선 효과에 대한 다기관 평가

Multicenter Evaluation on the Efficacy of N-Acetyl Cystine in Relieving the Symptoms of Laryngopharyngeal Reflux Disease

  • 김소연 (성균관대학교 의과대학 강북삼성병원 이비인후과학교실) ;
  • 권택균 (서울대학교 의과대학 이비인후과학교실) ;
  • 김한수 (이화여자대학교 의과대학 이비인후과학교실) ;
  • 손영익 (성균관대학교 의과대학 삼성서울병원 이비인후과학교실) ;
  • 우승훈 (경상대학교 의과대학 이비인후과학교실) ;
  • 우정수 (고려대학교 의과대학 구로병원 이비인후과학교실) ;
  • 이승원 (순천향대학교 의과대학 부천병원 이비인후과학교실) ;
  • 임재열 (연세대학교 의과대학 강남세브란스병원 이비인후과학교실) ;
  • 정만기 (성균관대학교 의과대학 삼성서울병원 이비인후과학교실) ;
  • 주영훈 (가톨릭대학교 의과대학 부천성모병원 이비인후과학교실) ;
  • 차원재 (부산대학교 의과대학 이비인후과학교실) ;
  • 최승호 (울산대학교 의과대학 서울아산병원 이비인후과학교실) ;
  • 홍현준 (가톨릭관동대학교 의과대학 이비인후과학교실) ;
  • 이상혁 (성균관대학교 의과대학 강북삼성병원 이비인후과학교실)
  • Kim, So Yean (Department of Otorhinolaryngology-Head and Neck Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Kwon, Tack Kyun (Department of Otorhinolaryngology, Seoul National University College of Medicine) ;
  • Kim, Han Su (Department of Otorhinolaryngology-Head and Neck Surgery, Ewha Womans University School of Medicine) ;
  • Son, Young Ik (Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Woo, Seung Hoon (Department of Otorhinolaryngology, Gyeongsang National University School of Medicine) ;
  • Woo, Jeong-Soo (Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine,) ;
  • Lee, Seung Won (Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine) ;
  • Lim, Jae Yol (Department of Otorhinolaryngology, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Chung, Man Ki (Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Joo, Young Hoon (Department of Otolaryngology-Head and Neck Surgery, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Cha, Wonjae (Department of Otorhinolaryngology-Head and Neck Surgery, Pusan National University Hospital, Pusan National University School of Medicine) ;
  • Choi, Seung Ho (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Hong, Hyun Jun (Department of Otorhinolaryngology-Head & Neck Surgery, International St. Mary's Hospital, Catholic Kwandong University College of Medicine) ;
  • Lee, Sang Hyuk (Department of Otorhinolaryngology-Head and Neck Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
  • 투고 : 2018.10.25
  • 심사 : 2018.11.08
  • 발행 : 2018.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background and Objectives : Laryngopharyngeal reflux disease (LPRD) is relatively common disease. N-acetyl cysteine (NAC) has both mucolytic and antioxidant effect, also may be beneficial in inflammatory airway diseases. The purpose of this study was to evaluate the efficacy and safety of inhaled NAC therapy in LPRD. Materials and Method : We retrospectively reviewed the medical records of 525 LPRD patients at 12 medical centers. Finally 401 patients subjected to inhaled NAC therapy for 2 months were enrolled in the study. We analyzed the change of Reflux Symptom Index (RSI) and Reflux Finding Score (RFS) after use of NAC for 4 weeks and 8 weeks in addition to the patient's compliance of the treatment. Results : The RSI score significantly decreased from $19.87{\pm}6.34$ to $12.78{\pm}6.93$ after 4 weeks and to $10.65{\pm}7.47$ after 8 weeks. The RFS score also significantly decreased from $9.29{\pm}3.4$ to $7.17{\pm}3.41$ after 4 weeks and to $6.1{\pm}3.73$ after 8 weeks (p<0.05). During the treatment periods, 42 patients (10.4%) reported to have 80 episodes of discomfort. Throat discomfort (33%) and nausea (28%) were most common complaints, but the duration of discomfort was usually less than 4 weeks. Conclusion : Inhaled NAC treatment is highly effective for the reduction of both subjective and objective findings in LPRD patients. This study will provide the evidence of new treatment option for patients with LPRD. However, further studies will be needs to assess the real effect of inhaled NAC therapy as a standard treatment regimen of LPRD.

키워드

참고문헌

  1. Lee YJ, Kwak MK, Eom JH, Ji YB, Song CM, Tae K. Optimal Regimen and Period for the Treatment of Patients with Laryngopharyngeal Reflux Disease. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 2014;57(10):698-702. https://doi.org/10.3342/kjorl-hns.2014.57.10.698
  2. Tae K, Lee YS, Kim SY, Jung JH, Lee SH, Park YW, et al. The diagnosis of laryngopharyngeal reflux: the role of esophageal mucosal biopsy. Korean Journal of Otolaryngology-Head and Neck Surgery 2006;49(1):79-84.
  3. Oh JH, Ji YB, Song CM, Jung JH, Jin BJ, Tae K. Correlation between ambulatory 24 hour dual probe pH monitoring and reflux finding score, reflux symptom index in the laryngopharyngeal reflux. Korean J Otorhinolaryngol-Head Neck Surg 2013;56(11):706-10. https://doi.org/10.3342/kjorl-hns.2013.56.11.706
  4. Berardi R. A critical evaluation of proton pump inhibitors in the treatment of gastroesophageal reflux disease. The American Journal of Managed Care 2000;6(9 Suppl):S491-505.
  5. Karkos P, Benton J, Leong S, Karkanevatos A, Badran K, Srinivasan V, et al. Trends in laryngopharyngeal reflux: a British ENT survey. European Archives of Oto-Rhino-Laryngology 2007;264(5):513-7. https://doi.org/10.1007/s00405-006-0222-8
  6. Yang Y-X, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. Jama 2006;296(24):2947-53. https://doi.org/10.1001/jama.296.24.2947
  7. des Varannes SB, Coron E, Galmiche J-P. Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs? Best Practice & Research Clinical Gastroenterology 2010;24(6):905-21. https://doi.org/10.1016/j.bpg.2010.09.004
  8. Masoompour SM, Anushiravani A, Norouz AT. Evaluation of the effect of nebulized N-acetylcysteine on respiratory secretions in mechanically ventilated patients: randomized clinical trial. Iranian Journal of Medical Sciences 2015;40(4):309.
  9. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). Journal of Voice 2002;16(2):274-7. https://doi.org/10.1016/S0892-1997(02)00097-8
  10. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). The Laryngoscope 2001;111(8):1313-7. https://doi.org/10.1097/00005537-200108000-00001
  11. Belafsky PC, Postma GN, Amin MR, Koufman JA. Symptoms and findings of laryngopharyngeal reflux. Ear, Nose & Throat Journal 2002;81(9):10. https://doi.org/10.1177/014556130208100103
  12. Kwon K-H, Ban J-H, Lee K-C. Revaluation of Reflux Finding Score (RFS) in Laryngopharyngeal Reflux (LPR). The Journal of the Korean Society of Logopedics and Phoniatrics;15.
  13. Lee SH, Huh SH. Recent trends of laryngopharyngeal reflux disease. Korean J Otorhinolaryngol-Head Neck Surg 2011;54(8):519-25. https://doi.org/10.3342/kjorl-hns.2011.54.8.519
  14. Ford CN. Evaluation and management of laryngopharyngeal reflux. Jama 2005;294(12):1534-40. https://doi.org/10.1001/jama.294.12.1534
  15. Lee JY, Chae R, Hong SJ, Lee SH, Jin SM. Clinical Analysis of High Resolution Manometry (HRM) in Patients with Laryngopharyngeal Reflux Disease. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 2013;56(10):637-41. https://doi.org/10.3342/kjorl-hns.2013.56.10.637
  16. Reichel O, Dressel H, Wiederanders K, Issing WJ. Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux. Otolaryngology-Head and Neck Surgery 2008;139(3):414-20. https://doi.org/10.1016/j.otohns.2008.06.003
  17. Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C, et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. The Laryngoscope 2005;115(7):1230-8. https://doi.org/10.1097/01.MLG.0000163746.81766.45
  18. Sadowska AM, Verbraecken J, Darquennes K, De Backer W. Role of N-acetylcysteine in the management of COPD. International Journal of Chronic Obstructive Pulmonary Disease 2006;1(4):425. https://doi.org/10.2147/copd.2006.1.4.425
  19. Prescott L, Ballantyne A, Proudfoot A, Park J, Adriaenssens P. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. The Lancet 1977;310(8035):432-4. https://doi.org/10.1016/S0140-6736(77)90612-2
  20. Mitchell J, Jollow D, Potter W, Gillette J, Brodie B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. Journal of Pharmacology and Experimental Therapeutics 1973;187(1):211-7.
  21. Uraz S, Tahan G, Aytekin H, Tahan V. N-acetylcysteine expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic acid-induced colitis in rats. Scandinavian Journal of Clinical and Laboratory Investigation 2013;73(1):61-6. https://doi.org/10.3109/00365513.2012.734859
  22. Dabirmoghaddam P, Amali A, Langroudi MM, Fard MRS, Hejazi M, Razavi MS. The effect of N-acetyl cysteine on laryngopharyngeal reflux. Acta Medica Iranica 2013;51(11):757-64.
  23. Lee SH, Jin SM, Johnston N. The role of pepsin in laryngopharyngeal reflux. Korean J Otorhinolaryngol-Head Neck Surg 2015;58(8):529-33. https://doi.org/10.3342/kjorl-hns.2015.58.8.529
  24. Woo J-S. Ultra-Structural and Molecular Aspects of Laryngopharyngeal Reflux. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 2009;52(5):394-400. https://doi.org/10.3342/kjorl-hns.2009.52.5.394